메뉴 건너뛰기




Volumn 90, Issue 2-3, 2014, Pages 61-68

The effects of aspirin and fish oil consumption on lysophosphatidylcholines and lysophosphatidic acids and their correlates with platelet aggregation in adults with diabetes mellitus

Author keywords

Aspirin; Docosahexaenoic acid; Eicosapentaenoic acid; Lysophosphatidic acid; Lysophosphatidylcholine; Omega 3 fatty acids; Platelet function

Indexed keywords

ASPIRIN; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; OMEGA-3 FATTY ACIDS; PLATELET FUNCTION;

EID: 84895910742     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.12.004     Document Type: Article
Times cited : (14)

References (39)
  • 1
    • 3242699423 scopus 로고    scopus 로고
    • Mechanisms of lysophosphatidic acid production
    • Aoki J. Mechanisms of lysophosphatidic acid production. Semin. Cell Dev. Biol. 2004, 15:477-489.
    • (2004) Semin. Cell Dev. Biol. , vol.15 , pp. 477-489
    • Aoki, J.1
  • 2
    • 67849122340 scopus 로고    scopus 로고
    • Regulation of blood and vascular cell function by bioactive lysophospholipids
    • Morris A.J., Panchatcharam M., Cheng H.Y., et al. Regulation of blood and vascular cell function by bioactive lysophospholipids. J. Thromb. Haemost. 2009, 7(Suppl. 1):38-43.
    • (2009) J. Thromb. Haemost. , vol.7 , Issue.SUPPL. 1 , pp. 38-43
    • Morris, A.J.1    Panchatcharam, M.2    Cheng, H.Y.3
  • 4
    • 0033536049 scopus 로고    scopus 로고
    • Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions
    • Siess W., Zangl K.J., Essler M., et al. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:6931-6936.
    • (1999) Proc. Natl. Acad. Sci. U. S. A. , vol.96 , pp. 6931-6936
    • Siess, W.1    Zangl, K.J.2    Essler, M.3
  • 5
    • 0035800886 scopus 로고    scopus 로고
    • Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids
    • Hayashi K., Takahashi M., Nishida W., et al. Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ. Res. 2001, 89:251-258.
    • (2001) Circ. Res. , vol.89 , pp. 251-258
    • Hayashi, K.1    Takahashi, M.2    Nishida, W.3
  • 6
    • 12144288490 scopus 로고    scopus 로고
    • Lysophosphatidic acid induces neointima formation through PPARgamma activation
    • Zhang C., Baker D.L., Yasuda S., et al. Lysophosphatidic acid induces neointima formation through PPARgamma activation. J. Exp. Med. 2004, 199:763-774.
    • (2004) J. Exp. Med. , vol.199 , pp. 763-774
    • Zhang, C.1    Baker, D.L.2    Yasuda, S.3
  • 7
    • 79955596968 scopus 로고    scopus 로고
    • Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium
    • Zhou Z., Subramanian P., Sevilmis G., et al. Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium. Cell Metab. 2011, 13:592-600.
    • (2011) Cell Metab. , vol.13 , pp. 592-600
    • Zhou, Z.1    Subramanian, P.2    Sevilmis, G.3
  • 8
    • 1542359873 scopus 로고    scopus 로고
    • Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
    • Umezu-Goto M., Kishi Y., Taira A., et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 2002, 158:227-233.
    • (2002) J. Cell Biol. , vol.158 , pp. 227-233
    • Umezu-Goto, M.1    Kishi, Y.2    Taira, A.3
  • 9
    • 0037131366 scopus 로고    scopus 로고
    • Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase
    • Tokumura A., Majima E., Kariya Y., et al. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem. 2002, 277:39436-39442.
    • (2002) J. Biol. Chem. , vol.277 , pp. 39436-39442
    • Tokumura, A.1    Majima, E.2    Kariya, Y.3
  • 10
    • 33745466418 scopus 로고    scopus 로고
    • Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development
    • van Meeteren L.A., Ruurs P., Stortelers C., et al. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol. Cell Biol. 2006, 26:5015-5022.
    • (2006) Mol. Cell Biol. , vol.26 , pp. 5015-5022
    • van Meeteren, L.A.1    Ruurs, P.2    Stortelers, C.3
  • 11
    • 79551636074 scopus 로고    scopus 로고
    • Structural basis of substrate discrimination and integrin binding by autotaxin
    • Hausmann J., Kamtekar S., Christodoulou E., et al. Structural basis of substrate discrimination and integrin binding by autotaxin. Nat. Struct. Mol. Biol. 2011, 18:198-204.
    • (2011) Nat. Struct. Mol. Biol. , vol.18 , pp. 198-204
    • Hausmann, J.1    Kamtekar, S.2    Christodoulou, E.3
  • 12
    • 79551646019 scopus 로고    scopus 로고
    • Crystal structure of autotaxin and insight into GPCR activation by lipid mediators
    • Nishimasu H., Okudaira S., Hama K., et al. Crystal structure of autotaxin and insight into GPCR activation by lipid mediators. Nat. Struct. Mol. Biol. 2011, 18:205-212.
    • (2011) Nat. Struct. Mol. Biol. , vol.18 , pp. 205-212
    • Nishimasu, H.1    Okudaira, S.2    Hama, K.3
  • 13
    • 0038043168 scopus 로고    scopus 로고
    • Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity
    • Ferry G., Tellier E., Try A., et al. Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity. J. Biol. Chem. 2003, 278:18162-18169.
    • (2003) J. Biol. Chem. , vol.278 , pp. 18162-18169
    • Ferry, G.1    Tellier, E.2    Try, A.3
  • 14
    • 84866005911 scopus 로고    scopus 로고
    • Lysophosphatidic acid in atherosclerotic diseases
    • Schober A., Siess W. Lysophosphatidic acid in atherosclerotic diseases. Br. J. Pharmacol. 2012, 167:465-482.
    • (2012) Br. J. Pharmacol. , vol.167 , pp. 465-482
    • Schober, A.1    Siess, W.2
  • 15
    • 77949492248 scopus 로고    scopus 로고
    • Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance
    • Lin M.E., Herr D.R., Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat. 2010, 91:130-138.
    • (2010) Prostaglandins Other Lipid Mediat. , vol.91 , pp. 130-138
    • Lin, M.E.1    Herr, D.R.2    Chun, J.3
  • 16
    • 79952842711 scopus 로고    scopus 로고
    • GPR92/LPA(5) lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques
    • Khandoga A.L., Pandey D., Welsch U., Brandl R., Siess W. GPR92/LPA(5) lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques. Cardiovasc. Res. 2011, 90:157-164.
    • (2011) Cardiovasc. Res. , vol.90 , pp. 157-164
    • Khandoga, A.L.1    Pandey, D.2    Welsch, U.3    Brandl, R.4    Siess, W.5
  • 17
    • 0141919734 scopus 로고    scopus 로고
    • Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo
    • Yoshida K., Nishida W., Hayashi K., et al. Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo. Circulation 2003, 108:1746-1752.
    • (2003) Circulation , vol.108 , pp. 1746-1752
    • Yoshida, K.1    Nishida, W.2    Hayashi, K.3
  • 18
    • 0037137299 scopus 로고    scopus 로고
    • Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease
    • Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.
    • (2002) Circulation , vol.106 , pp. 2747-2757
    • Kris-Etherton, P.M.1    Harris, W.S.2    Appel, L.J.3
  • 19
    • 45849092920 scopus 로고    scopus 로고
    • Influence of acetylsalicylate on plasma lysophosphatidic acid level in patients with ischemic cerebral vascular diseases
    • Li Z.G., Yu Z.C., Wang D.Z., et al. Influence of acetylsalicylate on plasma lysophosphatidic acid level in patients with ischemic cerebral vascular diseases. Neurol. Res. 2008, 30:366-369.
    • (2008) Neurol. Res. , vol.30 , pp. 366-369
    • Li, Z.G.1    Yu, Z.C.2    Wang, D.Z.3
  • 20
    • 77951634698 scopus 로고    scopus 로고
    • The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxin
    • Block R.C., Duff R., Lawrence P., et al. The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxin. Prostaglandins Leukot. Essent. Fatty Acids 2010, 82:87-95.
    • (2010) Prostaglandins Leukot. Essent. Fatty Acids , vol.82 , pp. 87-95
    • Block, R.C.1    Duff, R.2    Lawrence, P.3
  • 21
    • 84879000451 scopus 로고    scopus 로고
    • Effects of low-dose aspirin and fish oil on platelet function and NF-kappaB in adults with diabetes mellitus
    • Block R.C., Abdolahi A., Smith B., et al. Effects of low-dose aspirin and fish oil on platelet function and NF-kappaB in adults with diabetes mellitus. Prostaglandins Leukot. Essent. Fatty Acids 2013, 89:9-18.
    • (2013) Prostaglandins Leukot. Essent. Fatty Acids , vol.89 , pp. 9-18
    • Block, R.C.1    Abdolahi, A.2    Smith, B.3
  • 22
    • 84859247836 scopus 로고    scopus 로고
    • Executive summary: standards of medical care in diabetes - 2012
    • American Diabetes Association
    • Executive summary: standards of medical care in diabetes - 2012. Diabetes Care 2012, 32:S4-S10. American Diabetes Association.
    • (2012) Diabetes Care , vol.32
  • 23
    • 34248352504 scopus 로고    scopus 로고
    • Aspirin dose for the prevention of cardiovascular disease: a systematic review
    • Campbell C.L., Smyth S., Montalescot G., Steinhubl S.R. Aspirin dose for the prevention of cardiovascular disease: a systematic review. J. Am. Med. Assoc. 2007, 297:2018-2024.
    • (2007) J. Am. Med. Assoc. , vol.297 , pp. 2018-2024
    • Campbell, C.L.1    Smyth, S.2    Montalescot, G.3    Steinhubl, S.R.4
  • 24
    • 40749134619 scopus 로고    scopus 로고
    • Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway
    • Pamuklar Z., Lee J.S., Cheng H.Y., et al. Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway. Arterioscler. Thromb. Vasc. Biol. 2008, 28:555-561.
    • (2008) Arterioscler. Thromb. Vasc. Biol. , vol.28 , pp. 555-561
    • Pamuklar, Z.1    Lee, J.S.2    Cheng, H.Y.3
  • 25
    • 84864365428 scopus 로고    scopus 로고
    • Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes
    • Barber M.N., Risis S., Yang C., et al. Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS One 2012, 7:e41456.
    • (2012) PLoS One , vol.7
    • Barber, M.N.1    Risis, S.2    Yang, C.3
  • 26
    • 84971579967 scopus 로고
    • Anonymous, Collaborative overview of randomised trials of antiplatelet therapy - I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration, BMJ
    • Anonymous, Collaborative overview of randomised trials of antiplatelet therapy - I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration, BMJ, 308, 1994, pp. 81-106.
    • (1994) , vol.308 , pp. 81-106
  • 27
    • 0842277242 scopus 로고    scopus 로고
    • Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition, Circulation
    • S.M. Grundy, H.B. Brewer, Jr., J.I. Cleeman, S.C. Smith, Jr., C. Lenfant, Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition, Circulation, 109, 2004, pp. 433-438.
    • (2004) , vol.109 , pp. 433-438
    • Grundy, S.M.1    Brewer Jr., H.B.2    Cleeman, J.I.3    Smith Jr., S.C.4    Lenfant, C.5
  • 28
    • 0024406369 scopus 로고
    • Steering Committee of the Physicians' Health Study Research Group, Final report on the aspirin component of the ongoing Physicians' Health Study, N. Engl. J. Med.
    • Steering Committee of the Physicians' Health Study Research Group, Final report on the aspirin component of the ongoing Physicians' Health Study, N. Engl. J. Med., 321, 1989, pp. 129-135.
    • (1989) , vol.321 , pp. 129-135
  • 29
    • 34347340649 scopus 로고    scopus 로고
    • Evaluation of dose-related effects of aspirin on platelet function: results from the aspirin-induced platelet effect (ASPECT) study
    • Gurbel P.A., Bliden K.P., DiChiara J., et al. Evaluation of dose-related effects of aspirin on platelet function: results from the aspirin-induced platelet effect (ASPECT) study. Circulation 2007, 115:3156-3164.
    • (2007) Circulation , vol.115 , pp. 3156-3164
    • Gurbel, P.A.1    Bliden, K.P.2    DiChiara, J.3
  • 30
    • 33646761285 scopus 로고    scopus 로고
    • Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients
    • Ohmori T., Yatomi Y., Nonaka T., et al. Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients. J. Thromb. Haemost. 2006, 4:1271-1278.
    • (2006) J. Thromb. Haemost. , vol.4 , pp. 1271-1278
    • Ohmori, T.1    Yatomi, Y.2    Nonaka, T.3
  • 31
    • 0018152134 scopus 로고
    • Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?
    • Dyerberg J., Bang H.O., Stoffersen E., Moncada S., Vane J.R. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?. Lancet 1978, 2:117-119.
    • (1978) Lancet , vol.2 , pp. 117-119
    • Dyerberg, J.1    Bang, H.O.2    Stoffersen, E.3    Moncada, S.4    Vane, J.R.5
  • 32
    • 0020693482 scopus 로고
    • Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects
    • Terano T., Hirai A., Hamazaki T., et al. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis 1983, 46:321-331.
    • (1983) Atherosclerosis , vol.46 , pp. 321-331
    • Terano, T.1    Hirai, A.2    Hamazaki, T.3
  • 33
    • 1042268057 scopus 로고    scopus 로고
    • Aspirin therapy in diabetes
    • Colwell J.A. Aspirin therapy in diabetes. Diabetes Care 2004, 27(Suppl. 1):S72-S73.
    • (2004) Diabetes Care , vol.27 , Issue.SUPPL. 1
    • Colwell, J.A.1
  • 34
    • 10944239058 scopus 로고    scopus 로고
    • ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction)
    • Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004, 110:e82-292.
    • (2004) Circulation , vol.110
    • Antman, E.M.1    Anbe, D.T.2    Armstrong, P.W.3
  • 35
    • 0022623355 scopus 로고
    • Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma
    • Tokumura A., Harada K., Fukuzawa K., Tsukatani H. Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma. Biochim. Biophys. Acta 1986, 875:31-38.
    • (1986) Biochim. Biophys. Acta , vol.875 , pp. 31-38
    • Tokumura, A.1    Harada, K.2    Fukuzawa, K.3    Tsukatani, H.4
  • 36
    • 65449156892 scopus 로고    scopus 로고
    • Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis
    • Pamuklar Z., Federico L., Liu S., et al. Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis. J. Biol. Chem. 2009, 284:7385-7394.
    • (2009) J. Biol. Chem. , vol.284 , pp. 7385-7394
    • Pamuklar, Z.1    Federico, L.2    Liu, S.3
  • 37
    • 64849095442 scopus 로고    scopus 로고
    • Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo
    • Tomsig J.L., Snyder A.H., Berdyshev E.V., et al. Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo. Biochem. J. 2009, 419:611-618.
    • (2009) Biochem. J. , vol.419 , pp. 611-618
    • Tomsig, J.L.1    Snyder, A.H.2    Berdyshev, E.V.3
  • 38
    • 77952173274 scopus 로고    scopus 로고
    • Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation
    • Albers H.M., Dong A., van Meeteren L.A., et al. Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7257-7262.
    • (2010) Proc. Natl. Acad. Sci. U. S. A. , vol.107 , pp. 7257-7262
    • Albers, H.M.1    Dong, A.2    van Meeteren, L.A.3
  • 39
    • 82955187784 scopus 로고    scopus 로고
    • Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome
    • Dohi T., Miyauchi K., Ohkawa R., et al. Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome. Clin. Chim. Acta 2012, 413:207-212.
    • (2012) Clin. Chim. Acta , vol.413 , pp. 207-212
    • Dohi, T.1    Miyauchi, K.2    Ohkawa, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.